BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Prognosis
53 results:

  • 1. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
    Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
    J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases.
    Bai K; Chen X; Qi X; Zhang Y; Zou Y; Li J; Yu L; Li Y; Jiang J; Yang Y; Liu Y; Feng S; Bu H
    J Neurooncol; 2023 Oct; 165(1):149-160. PubMed ID: 37897649
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations.
    Aoki K; Nishito Y; Motoi N; Arai Y; Hiraoka N; Shibata T; Sonobe Y; Kayukawa Y; Hashimoto E; Takahashi M; Fujii E; Nishizawa T; Fukuda H; Ohashi K; Arai K; Mizoguchi Y; Yoshida Y; Watanabe SI; Yamashita M; Kitano S; Sakamoto H; Nagata Y; Mitsumori R; Ozaki K; Niida S; Kanai Y; Hirayama A; Soga T; Maruyama T; Tsukada K; Yabuki N; Shimada M; Kitazawa T; Natori O; Sawada N; Kato A; Yoshida T; Yasuda K; Mizuno H; Tsunoda H; Ochiai A
    Cancer Res Commun; 2023 Jun; 3(6):1026-1040. PubMed ID: 37377611
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Epigenetic and genetic inactivation of tumor suppressor miR-135a in non-small-cell lung cancer.
    Choi JE; Jeon HS; Wee HJ; Lee JY; Lee WK; Lee SY; Yoo SS; Choi SH; Kim DS; Park JY
    Thorac Cancer; 2023 Apr; 14(11):1012-1020. PubMed ID: 36869643
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effect of short-term storage of blood samples on gene expression in lung cancer patients.
    Obermayr E; Koppensteiner N; Heinzl N; Schuster E; Holzer B; Fabikan H; Weinlinger C; Illini O; Hochmair MJ; Zeillinger R
    Clin Chem Lab Med; 2023 Jan; 61(2):294-301. PubMed ID: 36395488
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis.
    Flörsch B; Taugner J; Käsmann L; Kenndoff S; Guggenberger J; Tufman A; Reinmuth N; Duell T; Belka C; Eze C; Manapov F
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3267-3276. PubMed ID: 35915184
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Apoptosis-related genes-based prognostic signature for osteosarcoma.
    Yang F; Zhang Y
    Aging (Albany NY); 2022 May; 14(9):3813-3825. PubMed ID: 35504036
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tumorigenic effect of
    Yang L; Li N; Wang M; Zhang YH; Yan LD; Zhou W; Yu ZQ; Peng XC; Cai J
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278503
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Inhibition of DKC1 induces telomere-related senescence and apoptosis in lung adenocarcinoma.
    Kan G; Wang Z; Sheng C; Yao C; Mao Y; Chen S
    J Transl Med; 2021 Apr; 19(1):161. PubMed ID: 33879171
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations.
    Han J; Fu C; Li B
    Radiat Oncol; 2021 Mar; 16(1):47. PubMed ID: 33663551
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
    Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
    Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Sequential Versus Concurrent Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for N3 Limited-Stage Small-Cell lung cancer.
    Wang Z; Wan J; Liu C; Li L; Dong X; Geng H
    Cancer Control; 2020; 27(1):1073274820956619. PubMed ID: 32951452
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular characterisation and clinical correlation of papillary thyroid microcarcinoma.
    Samà MT; Grosso E; Mele C; Laurora S; Monzeglio O; Marzullo P; Boldorini R; Aluffi Valletti P; Aimaretti G; Scatolini M; Pagano L
    Endocrine; 2021 Jan; 71(1):149-157. PubMed ID: 32621051
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup.
    Pirker C; Bilecz A; Grusch M; Mohr T; Heidenreich B; Laszlo V; Stockhammer P; Lötsch-Gojo D; Gojo J; Gabler L; Spiegl-Kreinecker S; Dome B; Steindl A; Klikovits T; Hoda MA; Jakopovic M; Samarzija M; Mohorcic K; Kern I; Kiesel B; Brcic L; Oberndorfer F; Müllauer L; Klepetko W; Schmidt WM; Kumar R; Hegedus B; Berger W
    Clin Cancer Res; 2020 Jul; 26(14):3819-3830. PubMed ID: 32317288
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Association between Telomere-Related Polymorphisms and the Risk of IPF and COPD as a Precursor Lesion of lung cancer: Findings from the Fukuoka Tobacco-Related lung Disease (FOLD) Registry.
    Arimura-Omori M; Kiyohara C; Yanagihara T; Yamamoto Y; Ogata-Suetsugu S; Harada E; Hamada N; Tsuda T; Takata S; Shimabukuro I; Nagata N; Yatera K; Torii R; Okamoto M; Fujita M; Nakanishi Y
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):667-673. PubMed ID: 32212792
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival.
    Quetel L; Meiller C; Assié JB; Blum Y; Imbeaud S; Montagne F; Tranchant R; de Wolf J; Caruso S; Copin MC; Hofman V; Gibault L; Badoual C; Pintilie E; Hofman P; Monnet I; Scherpereel A; Le Pimpec-Barthes F; Zucman-Rossi J; Jaurand MC; Jean D
    Mol Oncol; 2020 Jun; 14(6):1207-1223. PubMed ID: 32083805
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Urothelial cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile.
    Hoffman-Censits J; Choi W; Pal S; Trabulsi E; Kelly WK; Hahn NM; McConkey D; Comperat E; Matoso A; Cussenot O; Cancel-Tassin G; Fong MHY; Ross J; Madison R; Ali S
    Eur Urol Oncol; 2021 Apr; 4(2):297-300. PubMed ID: 32061548
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case.
    Stenman A; Hellgren LS; Jatta K; Hysek M; Zemmler M; Altena R; Nilsson IL; Bränström R; Zedenius J; Juhlin CC
    Endocr Pathol; 2020 Mar; 31(1):77-83. PubMed ID: 32016808
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies.
    Hu X; Xia B; Bao Y; Xu YJ; Wang J; Ma HL; Peng F; Jin Y; Fang M; Tang HR; Chen MY; Dong BQ; Jin JN; Fu XL; Chen M
    Strahlenther Onkol; 2020 Feb; 196(2):172-181. PubMed ID: 31784801
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Metastatic location of extensive stage small-cell lung cancer: implications for thoracic radiation.
    Zhang H; Deng L; Wang X; Wang D; Teng F; Yu J
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2605-2612. PubMed ID: 31410604
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.